Menlo Park, CA, United States of America

Peng Wang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Recode Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peng Wang. Retrieved from https://idiyas.com/inventor/peng-wang-2knluwnr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Peng Wang: Innovator in Lipid Nanoparticle Compositions

Introduction

Peng Wang is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of pharmaceutical compositions, particularly through his innovative work with lipid nanoparticles.

Latest Patents

Peng Wang holds a patent for "Lipid nanoparticle compositions and uses thereof." This patent includes aerosolized pharmaceutical compositions that comprise aerosol particles, specifically lipid nanoparticles (LNPs). The patent also outlines methods for administering these aerosolized pharmaceutical compositions, showcasing his commitment to advancing medical technology.

Career Highlights

Currently, Peng Wang is associated with Recode Therapeutics, Inc., where he continues to push the boundaries of innovation in the pharmaceutical industry. His work focuses on developing cutting-edge solutions that can improve drug delivery systems.

Collaborations

Peng collaborates with talented individuals such as Sahitya Katikaneni and Neda Mahmoudi, contributing to a dynamic research environment that fosters innovation and creativity.

Conclusion

Peng Wang's contributions to lipid nanoparticle technology exemplify the impact of innovative thinking in the pharmaceutical field. His work not only enhances drug delivery methods but also paves the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…